NewsRx

Search our medical news database

Breast Cancer

Phase I Cancer Treatment System Clinical Trial Completed

Published in Women's Health Weekly, August 24th, 2000

Celsion Corp. (CLN), Columbia, Maryland, announced all 10 patients required to complete Phase I Clinical Trials for its patented Breast Cancer Treatment System have been treated.

The company expects, within 45-60 days, to report results of this feasibility and safety trial to the U.S. Food and Drug Administration and apply for permission to begin the final and pivotal Phase II multi-center trials necessary to obtain approval for commercialization.

Celsion's approach differs significantly from current breast cancer therapies. It is a minimally invasive outpatient procedure. The patient undergoes a single focused heat treatment using tumor-targeting...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook